Alkyl Amines Chemicals quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	528	406	+30.2%
EBITDA	134	76.6	+74.5%
EBITDA margin	25.3%	18.9%	+6.4 pts
Profit before tax	125	66.3	+87.9%
Net profit	94.6	49.4	+91.4%
EPS	₹18.50	₹9.67	+91.3%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	528	387	354	389	406	386	371	415	400	357	322	352	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	9.3	8.3	8.0	7.4	8.0	9.3	6.6	9.2	4.7	2.6	4.6	2.4
	537	395	362	397	413	395	378	424	404	359	327	355
	316	186	195	192	218	217	191	216	210	199	169	193
	−48.0	23.4	−10.2	13.7	1.5	−7.8	0.3	10.4	1.5	−18.1	−0.7	−2.2
	36.3	28.9	26.8	27.2	27.3	24.8	26.1	26.8	25.9	23.7	23.3	23.1
	0.4	0.3	0.2	0.3	0.3	0.2	0.9	0.4	0.2	0.7	1.1	1.7
	17.8	17.9	17.7	18.2	17.9	17.6	17.9	18.0	17.7	17.4	16.8	12.5
	90.1	77.8	75.6	86.6	81.8	84.5	82.3	88.1	83.0	83.0	70.5	89.5
	413	334	305	338	347	336	319	360	339	306	280	318
	134	70.7	67.2	70.2	76.6	67.8	71.2	73.5	79.1	68.9	59.6	48.3
	116	52.8	49.5	52.0	58.7	50.2	53.3	55.5	61.4	51.4	42.8	35.8
Profit
	125	60.8	57.2	59.1	66.3	59.4	59.1	64.3	65.9	53.3	46.3	36.4
	125	60.8	57.2	59.1	66.3	59.4	59.1	64.3	65.9	53.3	46.3	36.4
	28.6	13.3	11.8	13.8	14.2	9.9	11.7	12.9	13.3	10.0	6.7	4.0
	1.4	2.1	3.2	2.3	2.7	3.4	3.6	4.0	3.8	4.9	6.2	5.2
	30.0	15.4	15.0	16.2	16.9	13.3	15.3	16.9	17.0	14.9	12.9	9.2
	94.6	45.4	42.3	42.9	49.4	46.0	43.8	47.5	48.9	38.5	33.4	27.2
	94.6	45.4	42.3	42.9	49.4	46.0	43.8	47.5	48.9	38.5	33.4	27.2
	−0.2	1.8	−0.0	−1.6	−0.0	0.4	−0.4	−1.0	−0.4	0.5	−0.5	−0.6
	94.4	47.2	42.2	41.4	49.4	46.4	43.4	46.5	48.5	38.9	33.0	26.6
Per share
	₹18.50	₹8.87	₹8.26	₹8.40	₹9.67	₹9.00	₹8.56	₹9.28	₹9.56	₹7.52	₹6.54	₹5.33
	₹18.47	₹8.86	₹8.25	₹8.38	₹9.65	₹8.99	₹8.55	₹9.27	₹9.55	₹7.51	₹6.53	₹5.32
Other comprehensive income — detail
	−0.2	1.8	−0.0	−1.6	−0.0	0.4	—	—	—	—	—	—
	−0.2	1.8	−0.1	−2.1	−0.4	1.2	−0.9	−1.3	−0.5	0.4	−0.8	−1.0
	−0.0	−0.5	−0.0	−0.5	0.1	0.3	—	—	—	—	—	—
	—	—	—	—	—	—	−0.2	−0.3	−0.1	0.1	−0.2	−0.3
	−0.1	−0.4	0.0	—	0.4	−0.7	0.4	−0.0	0.0	0.3	0.1	0.1
	−0.0	0.1	0.0	0.0	−0.1	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	0.1	−0.0	0.0	0.1	0.0	0.0
Per share — as-filed variants
	₹18.50	₹8.87	₹8.26	₹8.40	₹9.67	₹9.00	₹8.56	₹9.28	₹9.56	₹7.52	₹6.54	₹5.33
	₹18.47	₹8.86	₹8.25	₹8.38	₹9.65	₹8.99	₹8.55	₹9.27	₹9.55	₹7.51	₹6.53	₹5.32
Regulatory disclosures — filed alongside, not part of the P&L
	—	4.3	—	16.5	—	6.7	—	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	260	177	170	184	186	177	180	188	188	176	153	161
	49.2%	45.8%	47.9%	47.3%	45.8%	45.9%	48.4%	45.4%	47.0%	49.2%	47.6%	45.7%
Adjusted (ex-exceptional items) — derived
	125	60.8	57.2	59.1	66.3	59.4	59.1	64.3	65.9	53.3	46.3	36.4
	94.6	45.4	42.3	42.9	49.4	46.0	43.8	47.5	48.9	38.5	33.4	27.2
	₹18.50	₹8.87	₹8.26	₹8.40	₹9.67	₹9.00	₹8.56	₹9.28	₹9.56	₹7.52	₹6.54	₹5.33

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ALKYLAMINE₹1,653.80

Alkyl Amines Chemicals Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersBALAMINES AETHER ACI TECILCHEM ELLEN GHCL GNFC GSFCMcap ₹8,459 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	352.2	322.1	356.6	399.7	414.9	371.2	386.1	405.5	389.4	354.0	386.9	528.0
Other Income	2.4	4.6	2.6	4.7	9.2	6.6	9.3	8.0	7.4	8.0	8.3	9.3
Total Income	354.5	326.7	359.2	404.4	424.1	377.8	395.4	413.5	396.8	362.0	395.2	537.3
Expenses
+ Cost of Materials Consumed	193.4	169.4	199.2	210.2	216.1	191.3	216.8	218.3	191.6	194.7	186.2	316.1
+ Changes in Inventories	-2.2	-0.7	-18.1	1.5	10.4	0.3	-7.8	1.5	13.7	-10.2	23.4	-48.0
+ Employee Benefit Expense	23.1	23.3	23.7	25.9	26.8	26.1	24.8	27.3	27.2	26.8	28.9	36.3
+ Finance Costs	1.7	1.1	0.7	0.2	0.4	0.9	0.2	0.3	0.3	0.2	0.3	0.4
+ Depreciation & Amortisation	12.5	16.8	17.4	17.7	18.0	17.9	17.6	17.9	18.2	17.7	17.9	17.8
+ Other Expenses	89.5	70.5	83.0	83.0	88.1	82.3	84.5	81.8	86.6	75.6	77.8	90.1
Total Expenses	318.1	280.3	305.9	338.5	359.7	318.8	336.0	347.2	337.7	304.8	334.4	412.6
EBITDA	48.3	59.6	68.9	79.1	73.5	71.2	67.8	76.6	70.2	67.2	70.7	133.6
EBIT	35.8	42.8	51.4	61.4	55.5	53.3	50.2	58.7	52.0	49.5	52.8	115.8
Profit
PBT before Exceptional Items	36.4	46.3	53.3	65.9	64.3	59.1	59.4	66.3	59.1	57.2	60.8	124.7
Pretax Income	36.4	46.3	53.3	65.9	64.3	59.1	59.4	66.3	59.1	57.2	60.8	124.7
+ Current Tax	4.0	6.7	10.0	13.3	12.9	11.7	9.9	14.2	13.8	11.8	13.3	28.6
+ Deferred Tax	5.2	6.2	4.9	3.8	4.0	3.6	3.4	2.7	2.3	3.2	2.1	1.4
Tax Expense	9.2	12.9	14.9	17.0	16.9	15.3	13.3	16.9	16.2	15.0	15.4	30.0
Net Income	27.2	33.4	38.5	48.9	47.5	43.8	46.0	49.4	42.9	42.3	45.4	94.6
+ Net Income — Continuing Ops	27.2	33.4	38.5	48.9	47.5	43.8	46.0	49.4	42.9	42.3	45.4	94.6
+ Other Comprehensive Income	-0.6	-0.5	0.5	-0.4	-1.0	-0.4	0.4	-0.0	-1.6	-0.0	1.8	-0.2
Total Comprehensive Income	26.6	33.0	38.9	48.5	46.5	43.4	46.4	49.4	41.4	42.2	47.2	94.4
Per Share
Basic EPS	5.33	6.54	7.52	9.56	9.28	8.56	9.00	9.67	8.40	8.26	8.87	18.50
Diluted EPS	5.32	6.53	7.51	9.55	9.27	8.55	8.99	9.65	8.38	8.25	8.86	18.47
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.4	-0.0	-1.6	-0.0	1.8	-0.2
+ Items NOT to be Reclassified to P&L	-1.0	-0.8	0.4	-0.5	-1.3	-0.9	1.2	-0.4	-2.1	-0.1	1.8	-0.2
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.3	0.1	-0.5	-0.0	-0.5	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.3	-0.2	0.1	-0.1	-0.3	-0.2	—	—	—	—	—	—
+ Items to be Reclassified to P&L	0.1	0.1	0.3	0.0	-0.0	0.4	-0.7	0.4	—	0.0	-0.4	-0.1
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.2	-0.1	0.0	0.0	0.1	-0.0
+ Tax on Items to be Reclassified — alt tag	0.0	0.0	0.1	0.0	-0.0	0.1	—	—	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	5.33	6.54	7.52	9.56	9.28	8.56	9.00	9.67	8.40	8.26	8.87	18.50
Diluted EPS — Continuing Operations	5.32	6.53	7.51	9.55	9.27	8.55	8.99	9.65	8.38	8.25	8.86	18.47
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	—	6.7	—	16.5	—	4.3	—
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	160.9	153.4	175.6	188.0	188.4	179.6	177.1	185.7	184.0	169.5	177.3	260.0
Gross Margin %	45.70	47.62	49.23	47.04	45.40	48.38	45.88	45.79	47.26	47.88	45.83	49.23
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	36.4	46.3	53.3	65.9	64.3	59.1	59.4	66.3	59.1	57.2	60.8	124.7
Net Income Adj (tax-effected)	27.2	33.4	38.5	48.9	47.5	43.8	46.0	49.4	42.9	42.3	45.4	94.6
EPS Adj	5.33	6.54	7.52	9.56	9.28	8.56	9.00	9.67	8.40	8.26	8.87	18.50
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Filed Dscr	—	—	—	—	—	—	251.33	129.81	27.78	36.77	44.79	205.32
Filed Iscr	—	—	—	—	—	—	247.47	396.16	202.70	214.24	216.05	318.70
Paid Up Equity Capital	10.2	10.2	10.2	10.2	10.2	10.2	10.2	10.2	10.2	10.2	10.2	10.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Alkyl Amines Chemicals Q2 FY27 results date

Alkyl Amines Chemicals (NSE: ALKYLAMINE) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 14 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Standalone net profit was ₹94.6 crore, up 91.4% from ₹49.4 crore in Q1 FY26 and up 108.6% from ₹45.4 crore in Q4 FY26. Revenue from operations was ₹528 crore, up 30.2% year on year and up 36.5% from the previous quarter.

Board-meeting notice filed: 14 October 2026
Q2 FY26 results (a year earlier): 4 November 2025
Q1 FY27 results (the latest): 4 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · standalone

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 14 Oct
Q1 FY27 net profit: ₹94.6 Cr+91.4% vs Q1 FY26+108.6% vs Q4 FY26
Q1 FY27 revenue: ₹528 Cr+30.2% vs Q1 FY26+36.5% vs Q4 FY26
Q1 FY27 operating margin: 21.9%+7.5 pts vs Q1 FY26+8.3 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹42.9 CrRevenue ₹389 Cr
Q1 FY27 EPS (basic): ₹18.50

Questions

When will Alkyl Amines Chemicals announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 14 October 2026). Last year it reported Q2 FY26 on 4 November 2025.

What were Alkyl Amines Chemicals' Q1 FY27 results?

Standalone net profit was ₹94.6 crore, up 91.4% from ₹49.4 crore in Q1 FY26 and up 108.6% from ₹45.4 crore in Q4 FY26. Revenue from operations was ₹528 crore, up 30.2% year on year and up 36.5% from the previous quarter.

What was Alkyl Amines Chemicals' net profit in FY26?

Standalone net profit was ₹180 crore in FY26 (April 2025–March 2026), down 3.3% from ₹186 crore in FY25. It was ₹149 crore in FY24 and ₹229 crore in FY23: down 21.3% over three years, an average fall of 7.7% a year.

What will Alkyl Amines Chemicals' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when standalone net profit was ₹42.9 crore and revenue from operations ₹389 crore. The latest quarter, Q1 FY27, had a net profit of ₹94.6 crore and revenue of ₹528 crore.

How has Alkyl Amines Chemicals' profit changed over the last four quarters?

Net profit by quarter: ₹42.9 crore in Q2 FY26, ₹42.3 crore in Q3 FY26, ₹45.4 crore in Q4 FY26 and ₹94.6 crore in Q1 FY27. That is ₹225 crore over the four quarters, up 20.6% from ₹187 crore in the four quarters before. Revenue from operations: ₹389 crore, ₹354 crore, ₹387 crore and ₹528 crore.

What was Alkyl Amines Chemicals' revenue in FY26?

Revenue from operations was ₹1,536 crore in FY26 (April 2025–March 2026), down 2.3% from ₹1,572 crore in FY25. It was ₹1,441 crore in FY24 and ₹1,682 crore in FY23: down 8.7% over three years, an average fall of 3.0% a year.

Where do these Alkyl Amines Chemicals figures come from?

From Alkyl Amines Chemicals' own standalone results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Standalone figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.